Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Collins Foods Expansion Strategy On Track

Jun 28 2018

Despite a soft result in FY18, brokers remain confident in the longer-term ambitions of Collins Foods as the company’s expansion strategy is rolled out.


Codan In Line For Re-Rating?

May 21 2018

Strong demand for a number of metal detection and mining solution products has driven Codan to upgrade guidance, providing validation for a positive outlook from several brokers.


Ainsworth Profit Outlook Falls Short

May 08 2018

Ainsworth Game Technology has significantly downgraded guidance, made worse by the fact the revision includes a recent order from Churchill Downs.


Gage Roads’ Crafty Deal

May 04 2018

WA craft brewer Gage Roads has won exclusive beer rights to the new Perth stadium. DJ Carmichael initiates coverage.


Subdued Outlook For Aust Pharma Industries

Apr 26 2018

Soft retail conditions continue to cast a cloud over Australian Pharmaceutical Industries and brokers expect growth in FY18 will be a challenge.


Class Outlook More Subdued

Apr 12 2018

As the migration of AMP accounts continue and the easy wins in cloud conversions pass, Class is likely to experience a more subdued period over coming months.


Competitor Failures Bitter Sweet For Baby Bunting

Apr 11 2018

The baby goods retail industry has had its share of failures recently which puts Baby Bunting in the spotlight.


G Medical Launches Mobile Health Monitoring

Apr 10 2018

G Medical Innovations is a small medical device company with two key products it intends to distribute globally. TMT Analytics initiates coverage.


Medical Developments Pain Free In Germany

Apr 09 2018

Brokers welcome the news that Medical Developments has received regulatory approval to market its pain-killing device Penthrox in Germany.


Orthocell: Next Big Thing In Tissue Engineering?

Apr 06 2018

Regenerative medicine pioneer Orthocell closes in on market payday.



Analyse The Market From A Different Angle